W Gajewski

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Richard G. Moore, D. Scott McMeekin, Amy Brown et al. · Gynecologic Oncology · 2008 · 852 citations

Cancer Detection, Medicine, Pelvic Mass +8

Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass

Richard G. Moore, Michael Craig Miller, Paul DiSilvestro et al. · Obstetrics and Gynecology · 2011 · 326 citations

Incidence of metastasis to the ovaries from nongenital tract primary tumors

Richard G. Moore, Maureen Chung, C.O. Granai et al. · Gynecologic Oncology · 2004 · 227 citations

Surgical Oncology, Tumoral Pathology, Gynecological Surgery +7

Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study

Paul DiSilvestro, Shamshad Ali, Peter Craighead et al. · Journal of Clinical Oncology · 2014 · 123 citations · Full text

Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva

Richard G. Moore, Stephen DePasquale, Margaret M. Steinhoff et al. · Gynecologic Oncology · 2003 · 96 citations

Inguinal Lymph Nodes, Squamous Cell Cancer, Metastatic Tumor +8